Premium
Guided percutaneous fine‐needle aspiration biopsy of the liver
Author(s) -
Ho C. S.,
McLoughlin M. J.,
Tao L. C.,
Blendis L.,
Evans W. K.
Publication year - 1981
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19810401)47:7<1781::aid-cncr2820470710>3.0.co;2-q
Subject(s) - medicine , biopsy , malignancy , radiology , percutaneous , fine needle aspiration , complication , malignant disease , aspiration biopsy , liver disease , surgery , cancer , pathology
Forty patients with suspected malignant disease of the liver underwent percutaneous fine‐needle aspiration biopsy with radioisotope scintigraphic and fluoroscopic guidance. The needle was aimed at focal defects identified on the liver scan and several passes were made. When the scan was diffusely abnormal, the liver was widely sampled with multiple passes. Thirty patients were eventually considered to have malignant disease and aspiration biopsy was positive in 28 (93%) of these patients, including 25 of 26 with liver metastases (96%). There were two false‐positive results and one minor complication. In 24 patients, conventional wide‐bore needle biopsy was also performed. In this group, 16 patients had a final diagnosis of hepatic malignancy. Aspiration biopsies were positive in 14 of these (87%) and conventional needle biopsies were positive in four (25%). Guided percutaneous fine‐needle aspiration biopsy is recommended for pathologic diagnosis of hepatic malignancy because of its simplicity, high yield, and reasonable safety.